Susquehanna International Group’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.4M | Buy |
|
|||||
|
2025
Q2 | $558K | Buy |
|
|||||
|
2025
Q1 | $202K | Buy |
|
|||||
|
2024
Q4 | $70.2K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $314K | Sell |
|
|||||
|
2023
Q4 | $750K | Sell |
|
|||||
|
2023
Q3 | $989K | Buy |
|
|||||
|
2023
Q2 | $266K | Sell |
|
|||||
|
2023
Q1 | $1.57M | Buy |
|
|||||
|
2022
Q4 | $395K | Sell |
|
|||||
|
2022
Q3 | $1.19M | Buy |
|
|||||
|
2022
Q2 | $231K | Sell |
|
|||||
|
2022
Q1 | $1.08M | Sell |
|
|||||
|
2021
Q4 | $1.75M | Buy |
|
|||||
|
2021
Q3 | $761K | Sell |
|
|||||
|
2021
Q2 | $742K | Sell |
|
|||||
|
2021
Q1 | $1.03M | Sell |
|
|||||
|
2020
Q4 | $1.12M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $356K | Sell |
|
|||||
|
2020
Q1 | $712K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $1.42M | Sell |
|
|||||
|
2019
Q2 | $5.62M | Buy |
|
|||||
|
2019
Q1 | – | Hold |
|
|||||
|
2018
Q4 | – | Hold |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $1.04M | Buy |
|
|||||
|
2018
Q1 | $650K | Buy |
|
|||||
|
2017
Q4 | – | Hold |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $2.58M | Buy |
|
|||||
|
2017
Q1 | – | Hold |
|
|||||
|
2016
Q4 | – | Hold |
|
|||||
|
2016
Q3 | – | Hold |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $1.1M | Buy |
|
|||||
|
2015
Q4 | $927K | Sell |
|
|||||
|
2015
Q3 | $1.24M | Buy |
|
|||||
|
2015
Q2 | $572K | Sell |
|
|||||
|
2015
Q1 | $916K | Sell |
|
|||||
|
2014
Q4 | $3.31M | Buy |
|
|||||
|
2014
Q3 | $1.02M | Buy |
|
|||||
|
2014
Q2 | $379K | Buy |
|
|||||
|
2014
Q1 | $214K | Buy |
|